Instituto Nacional De Cancerologia De Mexico
Clinical trials sponsored by Instituto Nacional De Cancerologia De Mexico, explained in plain language.
-
Can a simple inhaler shield lung cancer patients from radiation side effects?
Disease control Recruiting nowThis study is for people with non-small cell lung cancer who are getting radiation and chemotherapy. It tests whether using inhaled steroids before and during treatment can reduce the severity of radiation pneumonitis, a common and serious lung inflammation. The trial will compar…
Phase: PHASE2 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Disease control
Last updated May 26, 2026 06:13 UTC
-
New study seeks best dose of alectinib for ALK-Positive lung cancer patients
Disease control Recruiting nowThis study is for people with advanced ALK-positive non-small cell lung cancer. It tests three different doses of the drug alectinib to find the safest and most effective level. The goal is to control the cancer and measure how the body processes the drug. About 45 participants w…
Phase: PHASE1, PHASE2 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
Heart drug may help radiation zap brain tumors in lung cancer patients
Disease control Recruiting nowThis study tests whether adding a nitroglycerin patch (a heart medication) to standard radiation therapy can better shrink brain tumors in people with a specific type of lung cancer (EGFR-mutant non-small cell lung cancer) that has spread to the brain. About 74 adults will be ran…
Phase: NA • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Diabetes drug metformin may boost lung cancer treatment in new trial
Disease control Recruiting nowThis phase 3 study tests whether adding the diabetes drug metformin to standard targeted therapy (tyrosine kinase inhibitors) can help control advanced non-small cell lung cancer with EGFR mutations. About 312 adults with stage IIIB or IV lung cancer will receive either metformin…
Phase: PHASE3 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
Gut shield: Probiotic-Diet combo may stop cancer drug side effect
Prevention Recruiting nowThis study tests whether adding glutamine and a probiotic (Lactobacillus reuteri) to a bland diet can prevent diarrhea caused by targeted therapy (TKIs) in people with advanced non-small cell lung cancer. About 28 participants will either get the standard diet or the diet plus su…
Phase: PHASE3 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Prevention
Last updated May 26, 2026 06:04 UTC
-
Lung cancer patients may breathe easier with pulmonary rehab
Symptom relief Recruiting nowThis study is testing whether a pulmonary rehabilitation program can help people with advanced non-small-cell lung cancer maintain muscle mass, improve lung function, and reduce inflammation. About 94 participants will take part while receiving standard cancer treatments like che…
Phase: NA • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Symptom relief
Last updated May 26, 2026 06:09 UTC
-
Could your body fat determine chemo safety?
Knowledge-focused Recruiting nowThis study looks at how a person's muscle and fat levels affect the side effects of chemotherapy for advanced lung cancer. Researchers want to see if adjusting the chemo dose based on body composition can reduce toxicity. About 132 patients will be followed to track side effects …
Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Knowledge-focused
Last updated May 26, 2026 06:02 UTC
-
Lung cancer rehab adherence scale under development
Knowledge-focused Recruiting nowThis study is creating a new questionnaire to measure how well people with lung cancer follow their breathing rehabilitation program. About 281 Mexican patients will fill out the 56-question scale. The goal is to make sure the tool is accurate and reliable, so doctors can better …
Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC
-
New study aims to detect lung cancer earlier in mexican smokers and Wood-Smoke exposed
Knowledge-focused Recruiting nowThis study will screen 1,000 people in Mexico aged 50 or older who are at high risk for lung cancer—including heavy smokers, former smokers, and those exposed to wood smoke—using low-dose CT scans each year for 3 years. The goal is to find lung cancer at an early stage when it's …
Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC